Dr. Brown is an assistant professor of pharmacy practice at Palm Beach Atlantic University, Lloyd L. Gregory School of Pharmacy,West Palm Beach, Fla.

The benefits of expanding dermatologic compounding in a pharmacy practice can be both rewarding and lucrative.

To avoid mix-ups with these and other commonly confused drug name pairs, alert staff and other practitioners about these types of errors.

This enzyme is increasingly involved in drug interactions as new medications metabolized by it are released.

This drug is a novel single-entity tablet, combining a dihydropyridine calcium channel blocker and an angiotensin receptor blocker.

This agent is the first FDA-approved product for the treatment of fibromyalgia.